Comparing Atorvastatin and Rosuvastatin Effects on Vitamin D Levels in Adults With Acute Coronary Syndrome

What this Trial Is About

This clinical trial involves patients with acute coronary syndrome who have normal Vitamin D levels. The study aims to evaluate how two different drugs, Atorvastatin and Rosuvastatin, affect Vitamin D levels over six months. Researchers will compare these drugs to understand their impact on increasing Vitamin D in this patient group. Participants will be randomly assigned to one of two groups one receiving Atorvastatin 40 mg once daily, and the other receiving Rosuvastatin 20 mg daily. Treatment will last for 24 weeks, after which Vitamin D levels will be measured to assess any changes caused by the medications. Throughout the study, patients will have their blood tested to measure Vitamin D levels at 24 weeks. Lipid profiles will also be checked at 4 and 24 weeks to monitor changes. The total participation duration is about six months, during which patients will be closely monitored for treatment effects and safety.

Impact of Atorvastatin Versus Rosuvastatin on 25 Hydroxy Vitamin D Levels in Patients With Acute Coronary Syndrome